BIOBIDE is going to participate in the “World Drug Targets Summit” that will be celebrated in Cambridge, Massachusetts from July 20th to 21st

BIOBIDE is going to participate in the “World Drug Targets Summit” that will be celebrated in Cambridge, Massachusetts from July 20th to 21st

Monday, 18 July 2011 09:47

BIOBIDE is going to participate in the “World Drug Targets Summit” that will be celebrated in Cambridge, Massachusetts from July 20th to 21st

Carles Callol (Scientific Director of BIOBIDE) is attending to The World Drug Targets Summit. This event is a cutting edge meeting that provides a great blend of senior executives and scientists from pharma/biotech companies and academia in the field to discuss different target identification and validation strategies.

BIOBIDE main aim is to accelerate Drug Discovery process minimizing risks through zebrafish animal model. Biobide offers Tailor Made Solutions depending on Customer´s requirements. For instance, Disease models in different therapeutic areas have been developed as well as the validation of diverse targets. The company has developed and validated several fast and cost-effective Toxicity (Cardiotoxicity, Hepatotoxicity, Teratogenesis, Acute Toxicity, Otic Toxicity) and Efficacy (Angiogenesis Inhibition) assays.